(Previosly known as Claris Otsuka Pvt.Ltd)

Otsuka Pharmaceutical India Pvt. Ltd. (OPI)

Company Introduction:

Otsuka Pharmaceutical India Pvt. Ltd. (OPI) is a leading pharmaceutical company in India, operating as a wholly-owned subsidiary of Otsuka Pharmaceutical Co., Ltd., Japan. The company specializes in the manufacturing and marketing of a diverse range of pharmaceutical products, with a primary focus on intravenous (IV) solutions, clinical nutrition products, and other critical care medications. OPI is committed to delivering high-quality, life-saving healthcare solutions to patients and healthcare providers across India. The company's operations encompass research and development, manufacturing in state-of-the-art facilities, and comprehensive distribution networks, all adhering to stringent international quality standards. OPI plays a crucial role in providing essential medicines and contributing to the healthcare landscape of India. The company was formerly known as Claris Otsuka Pvt. Ltd.

Nature of Business:

Otsuka Pharmaceutical India Pvt. Ltd. is primarily a manufacturer. They operate their own manufacturing facilities (factories) for the production of pharmaceutical products, including large volume parenterals and other injectable medicines. While they also handle the sales and distribution of these products, their core business function and identity are that of a manufacturing entity.

Otsuka Pharmaceutical India Pvt. Ltd. (formerly Claris Otsuka Pvt. Ltd.) manufactures and sells a range of pharmaceutical products and intravenous solutions.

The products include:

Intravenous (IV) Solutions:

Large Volume Parenterals (LVPs) such as Saline, Dextrose, Ringer's Lactate, and other electrolyte solutions.

Small Volume Parenterals (SVPs).

Specialized IV fluids including amino acid solutions, lipid emulsions, and total parenteral nutrition (TPN) products.

Pharmaceuticals (Prescription Drugs) across various therapeutic areas:

Central Nervous System (CNS) medications, primarily for psychiatric disorders like schizophrenia and bipolar disorder (e.g., Aripiprazole).

Oncology products for the treatment of various cancers.

Cardiovascular drugs.

Gastroenterology products.

Nephrology products, including those for conditions like hyponatremia.